Effects of Alum Adjuvant or a Booster Dose on Immunogenicityduring Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
AUTOR(ES)
Paoletti, L. C.
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127651Documentos Relacionados
- Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
- Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy
- Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
- Immunization with C5a Peptidase or Peptidase-Type III Polysaccharide Conjugate Vaccines Enhances Clearance of Group B Streptococci from Lungs of Infected Mice
- Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.